European Journal of Pharmacology 2007-01-12

Interactive effect of histamine and prostaglandin D2 on nasal allergic symptoms in rats.

Ashequr Rahman, Toshio Inoue, Jun Ago, Takashi Ishikawa, Chiaki Kamei

Index: Eur. J. Pharmacol. 554(2-3) , 229-34, (2007)

Full Text: HTML

Abstract

This study was undertaken to investigate the interactive effect of histamine and prostaglandin D(2) in nasal allergic symptoms in rats. The intranasal application of histamine at doses lower than 10 mumol/site caused no sneezing or nasal rubbing. In addition, prostaglandin D(2) also showed no significant increase in these responses, even at a dose of 10 nmol/site. On the other hand, the simultaneous instillation of histamine and prostaglandin D(2) resulted in a 1000 times more potent effect in inducing nasal symptoms than the administration of histamine alone. Thus, prostaglandin D(2) enhanced the actions of histamine in inducing sneezing and nasal rubbing in a dose-dependent manner, and significant effects were observed at doses higher than 1 nmol/site. The responses induced by the simultaneous application of histamine and prostaglandin D(2) were inhibited by chlorpheniramine, cyproheptadine, BW A868C and ramatroban. Chlorpheniramine and cyproheptadine showed the dose-related inhibition of nasal symptoms induced by the combined administration of histamine (10 nmol) and prostaglandin D(2) (10 nmol), but the effect of cyproheptadine was relatively weak compared with chlorpheniramine. Moreover, BW A868C and ramatroban also showed the inhibition of nasal symptoms induced by the simultaneous administration of histamine and prostaglandin D(2) in a dose-dependent manner. BW A868C was more potent in inhibiting the nasal symptoms than ramatroban. These results clearly indicate that prostaglandin D(2) showed a synergistic effect on sneezing and nasal rubbing induced by histamine in rats, and its effect occurred through both prostaglandin D(2) and CRTH2 (chemoattractant receptor-homologous molecule expressed on TH2 cells) receptors.


Related Compounds

  • Ramatroban
  • BW A868C

Related Articles:

IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model.

2009-01-01

[Int. Arch. Allergy Immunol. 149(4) , 315-22, (2009)]

Successful treatment of eosinophilic otitis media using ramatroban: report of two cases.

2006-12-01

[Auris. Nasus. Larynx. 33(4) , 455-60, (2006)]

Prophylactic effects of the histamine H1 receptor antagonist epinastine and the dual thromboxane A2 receptor and chemoattractant receptor-homologous molecule expressed on Th2 cells antagonist ramatroban on allergic rhinitis model in mice.

2011-01-01

[Biol. Pharm. Bull. 34(4) , 507-10, (2011)]

Effects of fexofenadine hydrochloride in a guinea pig model of antigen-induced rhinitis.

2005-10-01

[Pharmacology 75(2) , 76-86, (2005)]

Involvement of cyclooxygenase-2 in allergic nasal inflammation in rats.

2006-11-01

[Int. Immunopharmacol. 6(11) , 1736-42, (2006)]

More Articles...